Sponsored

Radiopharm Theranostics (ASX: RAD) to present at NWR Virtual Healthcare Conference - Kalkine Media

March 19, 2024 11:49 AM AEDT | By Sonal Goyal
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

Highlights

  • RAD would present at the NWR Virtual Healthcare Conference.
  • Vittorio Puppo, chief operating officer of RAD would deliver the presentation.

Radiopharm Theranostics Limited (ASX: RAD) informed that it will present at the NWR Virtual Healthcare Conference. The event is scheduled to happen on 20 – 21 March 2024. The presentation will be delivered by the chief operating officer of RAD, Vittorio Puppo on 21 March 2024 at 9:00 AM AEDT.

About Radiopharm Theranostics

RAD is a clinical stage radiotherapeutics company, focused on creating a platform of innovative radiopharmaceutical products for therapeutic and diagnostic applications in areas of high unmet medical needs.

The company manages a pipeline of different platform technologies covering small molecules, peptides and monoclonal antibodies. The technologies are being developed for use in cancer, clinical and pre-clinical stages of development from some of the leading institutes and universities. The pipeline of RAD have unique potential of being best in class or first to market.

The company is presently advancing RAD 301, RAD 302, RAD 101, RAD 204, RAD 202, RV01 trials.

RAD shares traded at AU$0.06 apiece at the time of writing o 19 March 2024.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

5 ASX Companies Leveraging AI to Drive Growth in 2024



Top ASX Listed Companies


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.